Monthly report from the EU Pharmacovigilance Risk Assessment Committee (PRAC) - July 2014

The EU Pharmacovigilance Risk Assessment Committee (PRAC) convened on 7-10 July 2014. Topics discussed at the meeting:

• PRAC issues recommendation for oral methadone products containing povidone.
• PRAC concludes review of Rienso.
• PRAC recommends restricted use for bromocriptine in inhibiting post-partum lactation.
• Update on the ongoing review of valproate and related substances.

Read PRAC's monthly report from the meeting 7-10 July 2014